Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma—Is It Based on Evidence or Clinical Wisdom?-Reference-Cited by-同舟云学术

Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma—Is It Based on Evidence or Clinical Wisdom?

Published:2021-12-01 Issue:12 Volume:7 Page:1759
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Gervaso Lorenzo¹²,Lordick Florian³,Fazio Nicola¹

Affiliation:

1. Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy

2. Molecular Medicine Program, University of Pavia, Pavia, Italy

3. Department of Oncology, Gastroenterology, Hepatology, Pulmonology, and Infectious Diseases, University Cancer Center Leipzig, Leipzig University Medical Center, Leipzig, Germany

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2784606/jamaoncology_gervaso_2021_vp_210017_1639155105.59501.pdf

Reference10 articles.

1. Validation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with pancreatic adenocarcinoma: a Surveillance, Epidemiology and End Results (SEER) analysis.;Kamarajah;Ann Surg Oncol,2017

2. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.;Neoptolemos;Lancet,2017

3. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer.;Conroy;N Engl J Med,2018

4. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.;Oettle;JAMA,2013

5. Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?;Ostapoff;HPB (Oxford),2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes of adjuvant chemotherapy in patients with stage I pancreatic cancer stratified by pathologic risk;Surgery;2024-08

2. Efficacy and safety of systemic chemotherapy for radically resectable esophago-gastric adenocarcinoma in older patients: A systematic review and meta-analysis;Journal of Geriatric Oncology;2024-01

3. Adjuvant chemotherapy in pancreatic cancer at different AJCC stages: a propensity score matching analysis;European Journal of Medical Research;2023-12-19

4. Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma;World Journal of Gastrointestinal Oncology;2023-01-15

5. Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data;Neoplasia;2022-12